The Immunology and Vaccines Business Unit is committed to fostering research and development into the discovery of vaccines and adjuvants capable of preventing and/or ameliorating immunolgical conditions that are rare, neglected, or othewise impact global health. Our research is focused on, but not limited to, leishmaniasis and other infectious, parasitic-born illnesses. Our goal is to ameliorate suffering. Our committment is complete.
